Searched for
DYNAVAX TECHNOLOGIES CORPORATION
Dynavax to supply its CpG 1018 adjuvant for Biological E's COVID-19 Vaccine CandidatePending conditional regulatory approvals in India, BE expects to commence product launch of Corbevax later this year.- Biological E gets nod for Phase III trial of its COVID-19 vaccine candidateIts candidate includes an antigen developed by the Texas Childrens Hospital Center for Vaccine Development and in- licensed from BCM Ventur...
- Biological E to start phase-III trials by January, license vaccine by summerDisclosing this in Hyderabad on Monday, managing director Mahima Datla said the company is currently evaluating four different formulations...
- Biological E gets DGCA nod to begin the next phase of trials for its COVID-19 vaccineThis vaccine candidate includes an antigen that was in-licensed from BCM Ventures, which is an integrated commercialisation team of Baylor ...
Load More